Navigation Links
GGZ-NML Hospital Deploys Ekahau RTLS for Staff Safety in Psychiatric Care Unit
Date:5/19/2008

As First to Deploy Ekahau in Netherlands, GGZ-NML Showcases Wi-Fi-Based

Location Tracking Application to More than 50 Dutch Healthcare

Organizations

SARATOGA, California, May 19 /PRNewswire/ -- Ekahau Inc., a leading provider of Wi-Fi-based Real Time Location Systems (RTLS), today announced that GGZ-NML, a hospital in Venray, The Netherlands, is the first healthcare organization in that country to use Ekahau RTLS to ensure the safety of its employees in the psychiatric care unit. The hospital also recently demonstrated its cutting-edge Ekahau application to more than 50 other Dutch healthcare organizations, showcasing how real-time location tracking can assist in rapidly and accurately finding employees who may be in dangerous situations.

"With unpredictable psychiatric patients under our care, our staff often finds themselves in a position where their personal safety can be compromised," said Erik Stijnen, project manager for ICT at GGZ-NML. "As we were renovating our facility, we realized that we needed a safety application that could easily integrate with our new wireless IP infrastructure. We tested several real-time location tracking applications, but only Ekahau met our demands for accuracy and rapid positioning."

To support GGZ-NML's staff safety requirements, systems integrator Zetacom deployed Ekahau RTLS, the only Wi-Fi-based location tracking solution that can operate over any brand or generation of Wi-Fi network. Hospital employees wear Ekahau's advanced Wi-Fi tags, which feature a panic button that can be pressed when they feel they are at risk. Through an application designed by Zetacom, the alarms are sent to Wi-Fi telephone handsets used by GGZ-NML's security department. Once notified of an alarm, the security staff can accurately determine the exact location of that employee and track their movement in real-time, so they can quickly react to the situation. Ekahau's tags are unique i
'/>"/>

SOURCE Ekahau Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
2. John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement
3. Sen. Edward Kennedy Hospitalized After Seizure
4. Partnership of academic centers and community hospitals effective model for disseminating advances
5. National Quality Forum Endorses Consensus Standards for Quality of Hospital Care
6. Hospital pay for performance incentives may backfire among safety-net hospitals
7. No Link Between Coarse Air Pollution, Hospitalizations
8. Quality Lags at Safety-Net Hospitals
9. Vibra Healthcare Acquires the Kindred Long Term Acute Care Hospital in Southeastern Michigan
10. Doctors Can Help Lower Hospital Costs
11. Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3